GLI2 and chondrosarcoma: We assessed the protein levels of GLI1 and GLI2 and found consistent results with the mRNA levels, suggesting that GANT-61 primarily reduces GLI1 expression rather than GLI2 in chondrosarcoma (Fig. 3J).